Meghmani Organics Ltd Q3 FY2023 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/3ypt0p7x4ll9remoosziwrep.pdf

Key Takeaways


TiO2: Commissioned, Stabilizing, Expanding

Ankit Patel: "It is not very easy to manufacture. That is why not every company is entering into this business and it is high CapEx nature."

Pigment Division: The Quarter's Drag

Ankit Patel: "So this has been a five years CAGR growth. So we have been consistently growing, so this is one of its quarter, you cannot have the growth continuously. There will be some ups and down in the business, so we feel this is one off quarter..."

Agrochemicals: Holding Margin, Building Pipeline


CDMO Contract: A Material, Opaque Win


Nano Urea: Policy Tailwind, Margin Unknown

Ankit Patel: "It is purely free market. There is no subsidy linkage to this product, so the government has no control on pricing. So anyone can sell at any price for this product."

Forex, Fire & Accounting Noise

Gurjant Singh Chahal: "We are very much cautious about it, but we have to take a trade off... Dollar also moved from 75 to 82 during the year... while Euro had moved only 84 to 88 relatively. But if you see the borrowing cost in dollar today, it is almost 6%, while euro it is around 2%-2.5%."

Guidance & Commitments

CommitmentSpecificsTimeline
TiO2 Phase 1 stabilizationPlant commissioned; stabilization in progress1.5–2 months (by ~Mar 2023)
TiO2 Phase 1 revenue~₹300 crore top line at current pricingFY24
TiO2 Phase 2 commissioningCapacity doubled to 33,000 tons + captive power plantEnd of Q3 FY24
Pigment demand recoveryNormalization expectedBy end of March; improvement from April
Overall EBITDA marginRecovery to 14%Going forward (no date)
Agrochemical segment growth15–20% growthFY24
New agrochemical MPP plant revenue₹300–350 crore (full-year potential ₹650 crore)FY24
CDMO contract revenue₹150–200 crore annually from the contractStarting FY24
Nano Urea commercial productionPlant commencementQ4 FY24
MCNL (Nano Urea) top line~₹1,000 crore on full-year annual basisFull-year run-rate (no date)
Insurance claim receiptFire claim under assessmentWithin one quarter
Debt repayment (scheduled)~₹98 crore next year, ~₹120 crore thereafterFY24 and beyond
Working capital range90–100 daysOngoing

Key Metrics

MetricQ3 FY23
Revenue (9M FY23)Nearly ₹2,000 cr, +18.5% YoY
Net profit (9M FY23)₹205 cr
EBITDA margin (9M FY23)14.1%
EBITDA margin (Q3 FY23)11.1%
Agrochemical division EBITDA marginNearly 19%
ROCE15% as on 31st December 2022
ROE18% as on 31st December 2022
Cash and cash equivalents₹77 cr as on 31st December
Debt to equity ratio0.43 as on 31st December
Gross debt: short-term~₹260 cr as on 31st December
Gross debt: long-term~₹430 cr as on 31st December
Net foreign currency loss (Q3 FY23)₹19 cr
Net foreign currency gain (9M FY23)₹35 cr
Borrowing cost net of forex impact (Q3 FY23)Nearly ₹5.5 cr
Borrowing cost net of forex impact (9M FY23)₹11.7 cr
Agrochemical revenue contribution~75% of overall revenue
Pigment revenue contribution~25% of overall revenue
Export revenue contribution~85% of overall revenue
Foreign currency exposure hedged60% to 65% via natural hedge
2,4D average price (Q3 FY23)~₹225
Cypermethrin price₹600–₹650, down from ₹650–₹700 three months ago
Agrochemical capacity utilization (ex-new plant)>75%, nearly 80%
Pigment capacity utilization~55% to 60%
Titanium dioxide Phase 1 capacity16,500 tons, commissioned 18th January 2023
Titanium dioxide Phase 1 expected top line (at current prices)Nearly ₹300 cr
Titanium dioxide Phase 2 completion targetQ3 FY24, doubling capacity to 33,000 tons per annum
New agrochemical MPP plant full-year revenue potential~₹650 cr
New agrochemical MPP plant expected FY24 revenue₹300–350 cr
CDMO contract value₹800 cr over five years, extendable
Nano urea plant CapExNearly ₹150 cr for capacity of 5 cr bottles per year
Nano urea plant commercial production startQ4 FY24
MCNL targeted top line (full-year annual basis)Nearly ₹1,000 cr
Nano urea project working capital requirement~₹200 cr on full-year basis
Fire loss: total~₹43 cr; ₹39 cr recognized as claim receivable, ₹4 cr accounted as loss
Annual debt repayment~₹98 cr next year, then ~₹120 cr as per schedule
Working capital days90–100 days
Five-year revenue CAGR (FY18–FY22)~20%
Five-year EBITDA CAGR (FY18–FY22)>20%, nearly 22%–23%
Five-year PAT CAGR (FY18–FY22)~40%